Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oklo Inc.CL A(OKLO) | 6,920,804 | 5,277,513 | -1,643,291 | $55.99M | $112.04M | 49.51% | +$56.05M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 5,941,120 | 5,941,120 | 0 | $39.15M | $40.16M | 17.75% | +$1.01M |
| Evolv Technologies Holdings, Inc.CL A(EVLV) | 9,681,281 | 9,681,281 | 0 | $39.21M | $38.24M | 16.90% | -$968.1K |
| Rocket Lab USA, Inc. | 2,929,350 | 1,377,943 | -1,551,407 | $28.50M | $35.10M | 15.51% | +$6.59M |
| Mind Medicine (MindMed) Inc. | 100,350 | 100,350 | 0 | $571.0K | $698.4K | 0.31% | +$127.4K |
| Roivant Sciences Ltd.SHS(ROIV) | 3,875 | 3,875 | 0 | $44.7K | $45.8K | 0.02% | +$1.1K |